Home » AGI Therapeutics Announces Positive Results From Phase II Study
AGI Therapeutics Announces Positive Results From Phase II Study
AGI Therapeutics plc announced positive results in a Phase II proof of concept study of AGI-004 in the control of chemotherapy-induced diarrhea.
RTTNews
RTTNews
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May